logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio

Jan 13, 2025•11 months ago

Acquiring Company

Cycle Pharmaceuticals

Acquired Company

Banner Life Sciences

CambridgeHigh PointPharmaceuticalBiotechnologyHealth CareBiotechnologyHealth CarePharmaceutical

Description

Cycle Pharmaceuticals, Inc. has successfully completed the acquisition of Banner Life Sciences, LLC including its BAFIERTAM® product for the treatment of relapsing forms of multiple sclerosis (MS), in adults, approved by the US Food and Drug Administration (FDA). With this acquisition, Cycle will broaden its MS product portfolio and strengthen its commitment to providing high-quality medicines and support to patients.

Company Information

Company

Cycle Pharmaceuticals

Location

Cambridge, England, United Kingdom

About

Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering drug treatments and product support to the underserved rare disease patient community. Cycle focuses on rare metabolic, immunological, and neurological genetic conditions. Within neurological conditions, we focus on multiple sclerosis. Cycle is headquartered in Cambridge, UK and has offices in Boston, Massachusetts.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed